Supernus Pharmaceuticals (SUPN) Q3 2024 Earnings

6AugConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-0.29
0.06
0.42
0.77

Details

Expected EPS
0.39
Actual EPS
0.770952
Surprise EPS
0.38
Surprise Percent
+97.68%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.770952 per share for Q3 2024.

0 Comments

Share your thoughts